CLASS II ONGOING Device recall · Reported 30 Sep 2026 · FDA Enforcement Report

Philips EPIQ Elite Diagnostic Ultrasound System recalled

Philips Ultrasound is recalling Philips EPIQ Elite Diagnostic Ultrasound System, distributed nationwide in the US. The recall was initiated on 7 Aug 2026 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesAll Philips EPIQ Elite Ultrasound Systems running software version 14.0, UDI(s): (01)00884838102514 (01)00884838107540 (01)00884838114159 (01)00884838124912 (01)00884838128125
Quantity recalled219 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-3249-2026
FDA event ID
99706
Recalling firm
Philips Ultrasound, Bothell, WA
Classification
Class II
Status
Ongoing
Recall initiated
7 Aug 2026
FDA classified
18 Sep 2026
Reported
30 Sep 2026
Type
Voluntary: Firm initiated
Reason category
Labeling Errors

Timeline

7 Aug 2026Recall initiated by company
18 Sep 2026Classified by FDA+42 days
30 Sep 2026Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Due to software issue with ultrasound system, doppler sample is displayed shallower than its actual measurement location, potentially causing inaccurate blood flow velocity measurements and misdiagnosis.

Product as listed by the FDA

Philips EPIQ Elite Diagnostic Ultrasound System Model # 795234

Where it was distributed

Worldwide - US Nationwide distribution in the states of AL, CA, CT, FL, GA, KS, MD, MN, NJ, NY, OH, PA, SC, TN, TX, VA, WA, WI and the countries of Austria, Denmark, Finland, France, Germany, Greece, Italy, Japan, Lithuania, Netherlands, Norway, Philippines, Poland, Romania, Slovenia, South Korea, Spain, Sweden, Switzerland, Taiwan , United Kingdom, Vietnam.

Nationwide AlabamaCaliforniaConnecticutFloridaGeorgiaKansasMarylandMinnesotaNew JerseyNew YorkOhioPennsylvaniaSouth CarolinaTennesseeTexasVirginiaWashingtonWisconsin

Questions about this recall

Why was it recalled?

Due to software issue with ultrasound system, doppler sample is displayed shallower than its actual measurement location, potentially causing inaccurate blood flow velocity measurements and misdiagnosis.

Which lots are affected?

All Philips EPIQ Elite Ultrasound Systems running software version 14.0, UDI(s): (01)00884838102514 (01)00884838107540 (01)00884838114159 (01)00884838124912 (01)00884838128125

Where was it sold?

Worldwide - US Nationwide distribution in the states of AL, CA, CT, FL, GA, KS, MD, MN, NJ, NY, OH, PA, SC, TN, TX, VA, WA, WI and the countries of Austria, Denmark, Finland, France, Germany, Greece, Italy, Japan, Lithuania, Netherlands, Norway, Philippines, Poland, Romania, Slovenia, South Korea, Spain, Sweden, Switzerland, Taiwan , United Kingdom, Vietnam.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 6 Oct 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Philips Ultrasound

All 109

Other Imaging Equipment recalls

All 2,341